What Primary Care Doctors Want You to Know About This Respiratory Virus Season

Practical takeaway: COVID-19, flu, and RSV continue to circulate across the United States. Most infections are mild, but older adults, infants, pregnant people, and those with chronic conditions remain at higher risk for serious illness. Vaccination, early testing when appropriate, and timely treatment can reduce complications.

As we move through the 2025–2026 respiratory virus season, primary care clinics across the country are seeing the familiar mix of influenza, COVID-19, and respiratory syncytial virus (RSV). According to the Centers for Disease Control and Prevention (CDC), seasonal respiratory viruses typically peak in fall and winter, though timing and intensity vary by year.

What’s circulating right now?

The CDC’s national respiratory virus surveillance shows continued activity from:

Influenza (flu)
COVID-19
RSV, especially affecting infants and older adults

Most cases cause mild to moderate illness—fever, cough, sore throat, congestion, fatigue—but some people develop complications such as pneumonia, worsening asthma or COPD, dehydration, or hospitalization.

Who is at higher risk?

Based on CDC guidance, people at increased risk of severe outcomes include:

Adults 65 and older
Infants and young children (especially under age 2 for RSV)
Pregnant people
People with chronic conditions such as heart disease, lung disease, diabetes, obesity, kidney disease, or weakened immune systems
Residents of nursing homes or long-term care facilities

Primary care clinicians pay special attention to these groups because early treatment can make a meaningful difference.

Vaccines: What the evidence shows

For influenza and COVID-19, updated seasonal vaccines are recommended annually. The CDC and the Advisory Committee on Immunization Practices (ACIP) review circulating strains and vaccine effectiveness data each year.

Flu vaccines do not prevent every infection, but decades of observational data show they reduce the risk of severe illness, hospitalization, and death—especially in older adults and people with chronic disease. Updated COVID-19 vaccines similarly target currently circulating variants and are designed to reduce severe outcomes.

For RSV, preventive options now include:

A monoclonal antibody product recommended for many infants entering their first RSV season
RSV vaccines recommended for adults 60 and older based on shared clinical decision-making, and for pregnant people during a specific gestational window to help protect newborns

These recommendations are based on randomized clinical trials showing reduced risk of severe RSV disease. As with any vaccine or preventive product, protection is not perfect, and mild side effects can occur. Ongoing monitoring continues through CDC and FDA safety systems.

Testing and early treatment matter

One change in primary care over the past several years is a stronger emphasis on early diagnosis. Antiviral medications for flu and COVID-19 work best when started within the first few days of symptoms. That means contacting your primary care clinician promptly if you are high risk and develop:

Fever or chills
Persistent cough
Shortness of breath
Sudden fatigue or body aches

Not everyone needs testing or prescription treatment. But people at higher risk for complications may benefit from evaluation, especially if symptoms are moderate or worsening.

When to seek urgent care

Seek emergency care for:

Trouble breathing
Chest pain or pressure
Confusion or difficulty staying awake
Signs of dehydration (especially in children and older adults)
Bluish lips or face

For infants, poor feeding, rapid breathing, or pauses in breathing are warning signs that require prompt evaluation.

Everyday prevention still works

Primary care doctors continue to recommend layered prevention strategies, especially for higher-risk households:

Stay up to date with recommended vaccines
Wash hands regularly
Stay home when sick
Improve indoor ventilation when possible
Consider masking in crowded indoor settings during periods of high community transmission

These steps may seem simple, but public health data consistently show they reduce spread—particularly in schools, workplaces, and multigenerational households.

Why this matters for primary care

Primary care practices serve as the first point of contact for most respiratory illnesses. They coordinate testing, prescribe antivirals when appropriate, manage chronic disease flare-ups, and help patients decide when home care is enough versus when escalation is needed.

For families, this season is a reminder that preventive care—vaccination, chronic disease management, and regular checkups—can reduce complications when infections do occur. Oral health also plays a supporting role: untreated dental infections and poor overall health can complicate recovery in medically vulnerable patients, underscoring the value of whole-person care.

What remains uncertain

Respiratory virus patterns shift year to year. Vaccine effectiveness varies depending on strain match and individual factors. Public health agencies continue to monitor variants, hospitalization rates, and vaccine performance. Recommendations may evolve as new data emerge.

What this means for readers

If you or a family member is at higher risk, make a plan now: confirm vaccination status, know how to reach your primary care clinician quickly, and understand early warning signs. For most healthy adults, respiratory infections are unpleasant but manageable. For vulnerable groups, timely prevention and treatment can reduce serious outcomes.

Staying informed—and connected to primary care—remains one of the most practical ways to protect your health this season.

Sources

Centers for Disease Control and Prevention (CDC) – Seasonal Influenza, COVID-19, and RSV Guidance
Food and Drug Administration (FDA) – Vaccine and Biologics Safety Monitoring
New England Journal of Medicine (NEJM) – Clinical trial data on RSV vaccines in older adults and pregnancy